Table 2.
Age group | 15–24 | 25–34 | 35–44 | 45–54 | 55–64 | 65 + |
---|---|---|---|---|---|---|
Male | ||||||
Tau | 0.14 | 0.71 | 0.10 | 0.71 | 0.14 | 0.24 |
p-value | 0.65 | 0.02 | 0.76 | 0.02 | 0.65 | 0.45 |
Female | ||||||
Tau | 0.43 | 0.33 | 0.05 | 0.14 | 0.14 | 0.05 |
p-value | 0.18 | 0.29 | 0.88 | 0.65 | 0.65 | 0.88 |
Age group | 15–24 | 25–34 | 35–44 | 45–54 | 55–64 | 65 + |
---|---|---|---|---|---|---|
Male | ||||||
Tau | 0.14 | 0.71 | 0.10 | 0.71 | 0.14 | 0.24 |
p-value | 0.65 | 0.02 | 0.76 | 0.02 | 0.65 | 0.45 |
Female | ||||||
Tau | 0.43 | 0.33 | 0.05 | 0.14 | 0.14 | 0.05 |
p-value | 0.18 | 0.29 | 0.88 | 0.65 | 0.65 | 0.88 |